Northwest Healthcare Properties Management Limited, the manager of Vital Healthcare Property Trust (Vital), advises that it expects Vital to record a property revaluation loss of ~NZ$160m for the six months ending 30 June 2023, with ~55% of the portfolio (by value) having been independently valued.
This preliminary draft revaluation loss represents a ~4.6% decrease since 31 December 2022 comprising a ~2.8% decrease for the Australian portfolio and a ~7.4% decrease for the New Zealand portfolio. The primary driver of this indicative result is 34 basis points of softening in the weighted average capitalisation rate for the portfolio (26 basis points softening for Australia and 52 basis points softening for New Zealand) taking the weighted average softening over FY23 to 48 basis points for the portfolio (34 basis points for Australia and 79 basis points for New Zealand).
The indicative weighted average capitalisation rate is expected to be 5.06% at 30 June 2023 reflecting 4.87% for the Australian portfolio and 5.48% for the New Zealand portfolio.
The indicative revaluation loss referred to above is subject to audit and will be confirmed when Vital's interim results are released (expected to occur on 10 August 2023).
Direct Capital onto its seventh fund after Christchurch firm investment.
The central bank is due to make a policy decision on Nov 27.
The 40% Crown-owned company’s other shareholders include Neil Craig and angel investors.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details